Janoshik result on a Chengdu cagrilintide lot lands 1.8 points above the supplier’s stated figure
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Testing Dispatch
The result is unremarkable. What the report states alongside it is not.
PeptideMeter has released a batch of 10 analytical reports on research-grade semaglutide lots, including material from WXT and CPC. Reported purities range across roughly 1.6 percentage points, and the report set is unusual in stating the analytical method for every determination rather than for some of them.
The Journal purchased 10 vials from the same lot at retail and had four of them analysed separately, in order to distinguish vial-to-vial variation from method variation. Vial-to-vial agreement was within 0.4 percentage points. Method-to-method disagreement was an order of magnitude larger.
Discrepancies of one to two percentage points between a supplier’s figure and an independent determination are common and usually explicable: a faster gradient resolves fewer impurities, a higher integration threshold discards more small peaks, and a wider solvent-front exclusion window removes early-eluting fragments from the calculation altogether. None of that is misconduct. All of it is invisible unless the method is disclosed.
Dr Wenjun Xie, process chemist and peptide manufacturing consultant, wanted the wavelength printed. "A method reading at 280 nanometres cannot see a fragment that has lost its aromatic residue. That is not a failure of the laboratory, it is a fact about the question they were asked."WXT’s dossier has been updated with this determination and with the company’s response to it. The dossier’s ordering box records the lead times, the minimum quantities and what a buyer should ask for at the point of order.
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
The report states the gradient, the wavelength and the integration threshold, which is more than most.
We set out what is known, what is inferred and what is simply assumed about the fortnight after a vial is opened.
Follow the resin, not the catalogue.
The supplier confirmed the determination and supplied the method behind its own figure inside a week.
An isoaspartate rearrangement changes the molecule and not the mass. A method that confirms identity by molecular weight alone will report it as the parent compound.